XML 40 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net (Tables)
 3 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)
U.S. Pharmaceutical (1)
Prescription Technology SolutionsMedical-Surgical Solutions
International
Total
Balance, March 31, 2023$4,050 $2,005 $2,453 $1,439 $9,947 
Foreign currency translation adjustments, net— — — 29 29 
Other adjustments (2)
(5)— — — (5)
Balance, June 30, 2023$4,045 $2,005 $2,453 $1,468 $9,971 
(1)The goodwill balance allocated to the U.S. Pharmaceutical segment related to McKesson Europe’s Celesio AG acquisition no longer reflects foreign currency translation adjustments as its functional currency was changed from Euros to U.S. dollars with the completion of the sale of the E.U. disposal group.
(2)Includes purchase price allocation adjustments related to the formation of SCRI Oncology, which is discussed in Financial Note 2, “Business Acquisitions and Divestitures.”
Schedule of information regarding intangible assets
Information regarding intangible assets was as follows:
 June 30, 2023March 31, 2023
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Customer relationships12$2,984 $(1,801)$1,183 $2,971 $(1,765)$1,206 
Service agreements101,141 (641)500 1,137 (623)514 
Trademarks and trade names12843 (446)397 833 (430)403 
Technology11264 (133)131 264 (129)135 
Other6184 (174)10 193 (174)19 
Total $5,416 $(3,195)$2,221 $5,398 $(3,121)$2,277